Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Bio N Tech Se Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $81.3 Billion
- Q2 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 3,127 shares of BNTX stock, worth $372,113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,127
Previous 2,378
31.5%
Holding current value
$372,113
Previous $219,000
14.61%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$985 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$570 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$521 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$348 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$226 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...